bilcare Research
Home  |  Contact Us
 
Increase text size Restore default text size Decrease text size
spurious drugs
Investors
Corporate Fact Sheet Financial Information Corporate Governance Investor Pack Investor FAQ Investor Contact
 
 

Corporate Fact Sheet

Bilcare Research (BSE: BI, CODE: 526853) is one of the world's leading providers of integrated solutions to the global pharmaceutical industry. Our sole focus is to fulfill the unmet needs of the pharmaceutical industry in the areas of packaging, clinical trial supplies and brand protection and management. We endeavour to enhance people's lives by helping pharmaceutical companies accelerate drug development lifecycles and combat counterfeit drugs. With a strong R&D and manufacturing base, we develop end-to-end, innovative and cost effective solutions for the entire pharmaceutical value chain.

Bilcare's Corporate Fact Sheet is updated on a quarterly basis and is intended to provide investors with a brief summary of news and events.

 Click here to download the Corporate Fact Sheet
 
 

Code of Conduct

Bilcare Stock Watch

 
© 2009-2010, Bilcare Limited. All Rights Reserved. Disclaimer Site Map Privacy Policy Content + Design Riteverses